Drug Shortage Report for KETAMINE HYDROCHLORIDE INJECTION USP

Last updated on 2024-01-30 History
Report ID 184644
Drug Identification Number 02246796
Brand name KETAMINE HYDROCHLORIDE INJECTION USP
Common or Proper name KETAMINE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-14
Estimated end date 2023-07-14
Actual end date 2023-07-17
Shortage status Resolved
Updated date 2024-01-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-01-30 English Compare
v9 2023-07-18 English Compare
v8 2023-07-17 French Compare
v7 2023-07-17 English Compare
v6 2023-04-11 French Compare
v5 2023-04-11 English Compare
v4 2023-02-28 English Compare
v3 2023-02-15 English Compare
v2 2023-02-14 French Compare
v1 2023-02-14 English Compare

Showing 1 to 10 of 10